Author: Frampton J.E. Wagstaff A.J.
Publisher: Adis International
ISSN: 0012-6667
Source: Drugs, Vol.63, Iss.12, 2003-01, pp. : 1229-1243
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Alemtuzumab: Coagulopathy: case report
Reactions Weekly, Vol. 1, Iss. 1192, 2008-01 ,pp. :
Increased risk of infections with alemtuzumab?
Reactions Weekly, Vol. 1, Iss. 1109, 2006-01 ,pp. :
Alemtuzumab effective in MS, but at a cost
Inpharma, Vol. 1, Iss. 1662, 2008-01 ,pp. :
Infection-related deaths with alemtuzumab consolidation
Reactions Weekly, Vol. 1, Iss. 1230, 2008-01 ,pp. :